CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 19,160 shares at $19.17 ($367K) on 2016-06-27, disclosed to the SEC on 2016-06-28.
Open-market purchase of $367k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.17 | 3,540 | $68K | 18.5% |
| 2 | $19.17 | 3,720 | $71K | 19.4% |
| 3 | $19.17 | 5,130 | $98K | 26.8% |
| 4 | $19.17 | 6,770 | $130K | 35.3% |
| Total | $19.17 avg | 19,160 | $367K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |